Editorial: Neurogenetic disorders: from the tests to the clinic

Shanshan Mao,Chunyu Li,Bo Yuan,Lan Yu,Huifang Shang

DOI: https://doi.org/10.3389/fneur.2023.1236350

IF: 3.4

2023-01-01

Frontiers in Neurology

Abstract:EDITORIAL article Front. Neurol., 12 July 2023Sec. Neurogenetics Volume 14 - 2023 | https://doi.org/10.3389/fneur.2023.1236350

What problem does this paper attempt to address?

Editorial: Genetic Mechanisms of Biomarkers in Schizophrenia, Bipolar Disorder and Depression

Yiguo Tang,Hongsheng Gui,Sarah Tarbox-Berry,Shaohua Hu,Xiancang Ma,Qiang Wang

DOI: https://doi.org/10.3389/fpsyt.2021.736055

IF: 4.7

2021-01-01

Frontiers in Psychiatry

Abstract:EDITORIAL article Front. Psychiatry, 12 August 2021Sec. Schizophrenia https://doi.org/10.3389/fpsyt.2021.736055
Editorial: Neuroendocrine Research in Health and Disease

Yu-Feng Wang,Keith Maurice Kendrick,Xue Qun Chen,Lei Sha

DOI: https://doi.org/10.3389/fnins.2020.00176

2020-01-01

Abstract:Department of Physiology, Harbin Medical University, Harbin, China, Division of Neurobiology and Physiology, Department of Basic Medical Sciences, School of Medicine, Zhejiang University, Hangzhou, China, Department of Neuroendocrine Pharmacology, School of Pharmacy, China Medical University, Shenyang, China, 4 Key Laboratory for Neuroinformation, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, China, 5 Faculty of Health Sciences, University of Macau, Shanghai, China, 6 School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China
Editorial: Genetics and epigenetics of psychiatric diseases—volume II

Qiyang Li,Yuanyuan Gai,Weihua Yue,Zhexing Wen,Chen Zhao

IF: 3.7

2022-01-01

Frontiers in Genetics

Abstract:EDITORIAL article Front. Genet., 13 October 2022Sec. Epigenomics and Epigenetics Volume 13 - 2022 | https://doi.org/10.3389/fgene.2022.1059855
Editorial: Application of Gene Editing in Pathology Dissection of Neurodegenerative Diseases.

Sen Yan,Xingshun Xu,Fangfang Qi,Xing Guo,Junhong Luo,Yujing Li

DOI: https://doi.org/10.3389/fnins.2022.1092176

IF: 4.3

2023-01-01

Frontiers in Neuroscience

Abstract:EDITORIAL article Front. Neurosci., 05 January 2023Sec. Neurodegeneration Volume 16 - 2022 | https://doi.org/10.3389/fnins.2022.1092176
Editorial for Brain Sciences Special Issue: "Neurogenetic Disorders across Human Life: From Infancy to Adulthood"

Paulo Ribeiro Nóbrega,Pedro Braga-Neto

DOI: https://doi.org/10.3390/brainsci14020111

IF: 3.333

2024-01-24

Brain Sciences

Abstract:This Special Issue assembles papers that highlight different types of neurogenetic disorders that occur throughout human life, from childhood to adulthood, focusing on their natural history, epidemiology, diagnosis, and treatment approaches [...]

neurosciences
Editorial: Using novel technologies and models to identify biomarkers and explore therapeutic strategies for neurological disorders.

Liwei Xing,Chengbiao Wu,Jiaojian Wang,Sheng Wei,Kai Yuan,Dongdong Qin

DOI: https://doi.org/10.3389/fnbeh.2023.1151667

IF: 3.617

2023-01-01

Frontiers in Behavioral Neuroscience

Abstract:EDITORIAL article Front. Behav. Neurosci., 23 March 2023Sec. Pathological Conditions Volume 17 - 2023 | https://doi.org/10.3389/fnbeh.2023.1151667
Editorial: Multi-modality imaging and multi-omics approach to pediatric neurogenetic disorders

Xinran Dong

DOI: https://doi.org/10.3389/fninf.2023.1192211

2023-01-01

Frontiers in Neuroinformatics

Abstract:EDITORIAL article Front. Neuroinform., 03 May 2023 Volume 17 - 2023 | https://doi.org/10.3389/fninf.2023.1192211
Editorial: Application of gene editing in neurodegenerative diseases, volume II

Fangfang Qi,Xingshun Xu,Xing Guo,Junhong Luo,Yujing Li,Sen Yan

DOI: https://doi.org/10.3389/fnins.2023.1305302

IF: 4.3

2023-01-01

Frontiers in Neuroscience

Abstract:EDITORIAL article Front. Neurosci., 31 October 2023Sec. Neurodegeneration Volume 17 - 2023 | https://doi.org/10.3389/fnins.2023.1305302
Editorial: Understanding the Heterogeneity and Spatial Brain Environment of Neurodegenerative Diseases Through Conventional and Future Methods

Cui Li,Marissa L Dubbelaar,Xiaoming Zhang,Jialin C Zheng

DOI: https://doi.org/10.3389/fncel.2023.1211273

2023-01-01

Frontiers in Cellular Neuroscience

Abstract:COPYRIGHT © 2023 Li, Dubbelaar, Zhang and Zheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Editorial: Understanding the heterogeneity and spatial brain environment of neurodegenerative diseases through conventional and future methods
Editorial: Antibody-Mediated Autoimmune Diseases of the CNS: Challenges and Approaches to Diagnosis and Management

Yin-Xi Zhang,Wei Qiu,Hong-Zhi Guan,Long-Jun Wu,Mei-Ping Ding

DOI: https://doi.org/10.3389/fneur.2022.844155

IF: 3.4

2022-01-01

Frontiers in Neurology

Abstract:EDITORIAL article Front. Neurol., 02 March 2022Sec. Multiple Sclerosis and Neuroimmunology https://doi.org/10.3389/fneur.2022.844155
Editorial: Sub-molecular Mechanism of Genetic Epilepsy.

Wei-Ping Liao,Qian Chen,Yu-Wu Jiang,Sheng Luo,Xiao-Rong Liu

DOI: https://doi.org/10.3389/fnmol.2022.958747

2022-01-01

Frontiers in Molecular Neuroscience

Abstract:EDITORIAL article Front. Mol. Neurosci., 26 July 2022Sec. Molecular Signalling and Pathways https://doi.org/10.3389/fnmol.2022.958747
Editorial: Insights in Pediatric Neurology: 2021

Ní Hóng,Pasquale Striano,Jo M Wilmshurst

DOI: https://doi.org/10.3389/fneur.2022.1041204

IF: 3.4

2022-01-01

Frontiers in Neurology

Abstract:COPYRIGHT © 2022 Ni, Striano and Wilmshurst. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Editorial: Insights in pediatric neurology: 2021
[Genetic testing in neurological diseases: a practical guide]

Claudia Arberas

Abstract:During the last decades, genomic medicine has made it possible to bring the knowledge of molecular genetics to the field of medical consultation. There are several studies that contribute to the diagnosis, the definition of prognoses, as well as the possibility of providing genetic counseling based on accurate scientific data. Advances in genomic sequencing have promoted the reclassification of entities according to an etiological criterion. Such is the case of epileptic encephalopathies, ataxias, dystonias, among many other neurological conditions. Its implementation requires strategies aimed at achieving the best diagnostic yield. This requires a greater understanding of the molecular bases of each of these practices, as well as their scope. They allow reducing the time until a certain diagnosis is made and the possibility, in some cases, of improving the quality of life of those affected with the use of tailored treatments. The objective of this article was to describe current laboratory studies, their scope and emphasize the algorithms for the study of genetic diseases in general, focusing the attention on those specific to neuropediatrics, in order to promote good practices, avoiding confusion, errors, and unnecessary expenditures of money and shortening the so-called "diagnostic odyssey".
Community series in neurobiological biomarkers for developing novel treatments of substance and non-substance addiction, volume II

Yehong Fang,Yi Liu,Ling Li,Dara G. Ghahremani,Jianhua Chen,Kyoji Okita,Wenbin Guo,Yanhui Liao

DOI: https://doi.org/10.3389/fpsyt.2023.1134561

IF: 4.7

2023-01-01

Frontiers in Psychiatry

Abstract:EDITORIAL article Front. Psychiatry, 13 April 2023Sec. Addictive Disorders Volume 14 - 2023 | https://doi.org/10.3389/fpsyt.2023.1134561
Editorial: Epilepsy syndromes: pathophysiology and managements

Hua-Jun Feng,Tao Sun,Bo Xiao

DOI: https://doi.org/10.3389/fneur.2023.1325553

IF: 3.4

2023-01-01

Frontiers in Neurology

Abstract:EDITORIAL article Front. Neurol., 13 November 2023Sec. Epilepsy Volume 14 - 2023 | https://doi.org/10.3389/fneur.2023.1325553
Navigating Neurogenetics for Child and Adolescent Psychiatry Practice

Aaron J Hauptman,Jay A Salpekar,Julie S Cohen,Miya R Asato,Aaron J. Hauptman,Jay A. Salpekar,Julie S. Cohen,Miya R. Asato

DOI: https://doi.org/10.1016/j.jaac.2023.09.555

IF: 13.113

2024-02-01

Journal of the American Academy of Child & Adolescent Psychiatry

Abstract:Neurodevelopmental disorders (NDDs) are a group of conditions characterized by impairments of brain processes that impact cognition, communication, motor abilities, and/or behavior during development. These conditions typically have significant effects across the life span and impact personal, social, academic, or occupational functioning. The US Centers for Disease Control and report that 1 in 6 children has a developmental disability, making it highly likely for child and adolescent psychiatrists to encounter children with NDDs in daily practice.1 While the etiologies of NDDs are broad, genetic syndromes are a common cause of NDDs. The diagnostic yield of thorough genetic testing for NDDs as a group is about 40% based on meta-analysis, including 30% to 50% yield in patients with global developmental delay (GDD) or intellectual disability (ID) and 15% to 20% yield in patients with in autism spectrum disorder.1-3 The findings are extremely heterogeneous, including chromosomal copy number variants (CNVs) and more than 2,000 known monogenic disorders associated with NDDs.3 Diagnostic yields will increase over time with advances in technology and disease gene discovery.3.

pediatrics,psychiatry,psychology, developmental
Editorial: Improving Diagnosis, Treatment, and Prognosis of Neuropsychiatric Disorders by Leveraging Neuroimaging-based Machine Learning

Baojuan Li,Huanyu Lu,Yu‐Feng Zang,Hui Shen,Qiuyun Fan,Jian Liu

DOI: https://doi.org/10.3389/fnins.2022.891337

IF: 4.3

2022-01-01

Frontiers in Neuroscience

Abstract:EDITORIAL article Front. Neurosci., 13 April 2022Sec. Brain Imaging Methods https://doi.org/10.3389/fnins.2022.891337
Editorial: Molecular Advances in Diagnosis and Treatment of CNS Tumors

Zhao Hui Zhang,Ming Tseh Lin,Liam Chen

DOI: https://doi.org/10.3389/fonc.2020.590293

IF: 4.7

2020-01-01

Frontiers in Oncology

Abstract:EDITORIAL article Front. Oncol., 25 September 2020Sec. Neuro-Oncology and Neurosurgical Oncology Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.590293
Editorial: Identifying Genetics-Based Mechanisms and Treatments for Neurodevelopmental and Psychiatric Disorders Through Data Integration

Kaifang Pang,Li Wang,Suhua Chang

DOI: https://doi.org/10.3389/fgene.2023.1186489

IF: 3.7

2023-01-01

Frontiers in Genetics

Abstract:Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States, Jan and Dan Duncan Neurological Research Institute, Texas Children’s Hospital, Houston, TX, United States, The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA, United States, Department of Neurology, University of California, San Francisco, San Francisco, CA, United States, Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China, Chinese Academy of Medical Sciences Research Unit (No 2018RU006), Peking University, Beijing, China
Editorial: Novel therapeutic target and drug discovery for neurological diseases

Kaiyue Zhao,Zhuorong Li,Qingshan Liu,Yong Cheng,George E. Barreto,Rui Liu

DOI: https://doi.org/10.3389/fphar.2022.1042266

IF: 5.6

2022-01-01

Frontiers in Pharmacology

Abstract:EDITORIAL article Front. Pharmacol., 07 October 2022Sec. Neuropharmacology https://doi.org/10.3389/fphar.2022.1042266

Editorial: Neurogenetic disorders: from the tests to the clinic

Editorial: Genetic Mechanisms of Biomarkers in Schizophrenia, Bipolar Disorder and Depression

Editorial: Neuroendocrine Research in Health and Disease

Editorial: Genetics and epigenetics of psychiatric diseases—volume II

Editorial: Application of Gene Editing in Pathology Dissection of Neurodegenerative Diseases.

Editorial for Brain Sciences Special Issue: "Neurogenetic Disorders across Human Life: From Infancy to Adulthood"

Editorial: Using novel technologies and models to identify biomarkers and explore therapeutic strategies for neurological disorders.

Editorial: Multi-modality imaging and multi-omics approach to pediatric neurogenetic disorders

Editorial: Application of gene editing in neurodegenerative diseases, volume II

Editorial: Understanding the Heterogeneity and Spatial Brain Environment of Neurodegenerative Diseases Through Conventional and Future Methods

Editorial: Antibody-Mediated Autoimmune Diseases of the CNS: Challenges and Approaches to Diagnosis and Management

Editorial: Sub-molecular Mechanism of Genetic Epilepsy.

Editorial: Insights in Pediatric Neurology: 2021

[Genetic testing in neurological diseases: a practical guide]

Community series in neurobiological biomarkers for developing novel treatments of substance and non-substance addiction, volume II

Editorial: Epilepsy syndromes: pathophysiology and managements

Navigating Neurogenetics for Child and Adolescent Psychiatry Practice

Editorial: Improving Diagnosis, Treatment, and Prognosis of Neuropsychiatric Disorders by Leveraging Neuroimaging-based Machine Learning

Editorial: Molecular Advances in Diagnosis and Treatment of CNS Tumors

Editorial: Identifying Genetics-Based Mechanisms and Treatments for Neurodevelopmental and Psychiatric Disorders Through Data Integration

Editorial: Novel therapeutic target and drug discovery for neurological diseases